The phospholipase D superfamily as therapeutic targets

Trends in Pharmacological Sciences

Volumn 36, Issue 3, 2015, Pages 137-144

  Frohman, Michael A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

autoimmune disease; cancer; PLD1; PLD2; small molecule inhibitors; thrombosis

Indexed keywords

PHOSPHOLIPASE D1; PHOSPHOLIPASE D2; PHOSPHOLIPASE INHIBITOR; ISOENZYME; PHOSPHOLIPASE D;

AUTOIMMUNE DISEASE; CELL ACTIVITY; DEGENERATIVE DISEASE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HYPERTENSION; INFECTION; INFLUENZA; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; RISK BENEFIT ANALYSIS; SIGNAL TRANSDUCTION; THROMBOSIS; ALZHEIMER DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; INFLUENZA, HUMAN; METABOLISM; NEOPLASMS;

ALZHEIMER DISEASE; ANIMALS; HUMANS; HYPERTENSION; INFLUENZA, HUMAN; ISOENZYMES; MULTIPLE SCLEROSIS; NEOPLASMS; PHOSPHOLIPASE D; THROMBOSIS;

EID: 84923935964     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2015.01.001     Document Type: Review

References (65)

1. X. Peng, and M.A. Frohman Mammalian phospholipase D physiological and pathological roles Acta Physiol. (Oxf.) 204 2012 219 226
2. P.E. Selvy Phospholipase D: enzymology, functionality, and chemical modulation Chem. Rev. 111 2011 6064 6119
3. M. Osisami A role for phospholipase D3 in myotube formation PLoS ONE 7 2012 e33341
4. Y. Otani PLD4 is involved in phagocytosis of microglia: expression and localization changes of PLD4 are correlated with activation state of microglia PLoS ONE 6 2011 e27544
5. S.Y. Choi A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis Nat. Cell Biol. 8 2006 1255 1262
6. E.E. Ha, and M.A. Frohman Regulation of mitochondrial morphology by lipids Biofactors 40 2014 419 424
7. C. Cruchaga Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease Nature 505 2014 550 554
8. C. Terao PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population Arthritis Rheum. 65 2013 472 480
9. S. Jung A nonsense mutation in PLD4 is associated with a zinc deficiency-like syndrome in Fleckvieh cattle BMC Genomics 15 2014 623
10. H. Huang piRNA-associated germline nuage formation and spermatogenesis require MitoPLD pro-fusogenic mitochondrial-surface lipid signaling Dev. Cell 20 2011 376 387
11. A. Gardin, and A. White The Sanger Mouse Genetics Programme: high throughput characterisation of knockout mice Acta Ophthalmol. 88 2011 10.1111/j.1755-3768.2011.4451.x Published online August 11, 2011
12. R. Anney A genome-wide scan for common alleles affecting risk for autism Hum. Mol. Genet. 19 2010 4072 4082
13. M.R. Ammar Lipids in regulated exocytosis: what are they doing? Front. Endocrinol. 4 2013 125
14. J.H. Jang Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners Prog. Lipid Res. 51 2012 71 81
15. A. Nishikimi Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis Science 324 2009 384 387
16. C. Zhao Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos Nat. Cell Biol. 9 2007 706 712
17. A. Honda Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation Cell 99 1999 521 532
18. D.A. Foster Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR) J. Biol. Chem. 289 2014 22583 22588
19. L.S. Csaki Lipins, lipinopathies, and the modulation of cellular lipid storage and signaling Prog. Lipid Res. 52 2013 305 316
20. J. Aoki Mechanisms of lysophosphatidic acid production Semin. Cell Dev. Biol. 15 2004 477 489
21. T. Baba Phosphatidic acid (PA)-preferring phospholipase A1 regulates mitochondrial dynamics J. Biol. Chem. 289 2014 11497 11511
22. A. Skippen Mechanism of ADP ribosylation factor-stimulated phosphatidylinositol 4,5-bisphosphate synthesis in HL60 cells J. Biol. Chem. 277 2002 5823 5831
23. W. Su 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis Mol. Pharmacol. 75 2009 437 446
24. T. Sato Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable Mol. Cell. Biol. 33 2013 136 145
25. Y. Kanaho Molecular mechanisms of fMLP-induced superoxide generation and degranulation in mouse neutrophils Adv. Biol. Regul. 53 2013 128 134
26. T.C. Sung Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity EMBO J. 16 1997 4519 4530
27. L. Yang CRISPR/Cas9-directed genome editing of cultured cells Curr. Protoc. Mol. Biol. 107 2014 31.31.31-31.31.17
28. A. Pupovac CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation Purinergic Signal. 9 2013 609 619
29. R.C. Bruntz Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer Pharmacol. Rev. 66 2014 1033 1079
30. Y. Zhang, and M.A. Frohman Cellular and physiological roles for phospholipase D1 in cancer J. Biol. Chem. 289 2014 22567 22574
31. Q. Chen Key roles for the lipid signaling enzyme phospholipase d1 in the tumor microenvironment during tumor angiogenesis and metastasis Sci. Signal. 5 2012 ra79
32. F. Sanematsu Phosphatidic acid-dependent recruitment and function of the Rac activator DOCK1 during dorsal ruffle formation J. Biol. Chem. 288 2013 8092 8100
33. D. Stegner Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke - brief report Arterioscler. Thromb. Vasc. Biol. 33 2013 2212 2217
34. C. Dall'Armi The phospholipase D1 pathway modulates macroautophagy Nat. Commun. 1 2010 142
35. A. Kulkarni 1,3-disubstituted-4-aminopyrazolo [3,4-d] pyrimidines, a new class of potent inhibitors for phospholipase D Chem. Biol. Drug Des. 84 2014 270 281
36. H. De Cuyper The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones Neuropsychobiology 12 1984 211 216
37. W.H. Ali Deficiencies of the lipid-signaling enzymes phospholipase D1 and D2 alter cytoskeletal organization, macrophage phagocytosis, and cytokine-stimulated neutrophil recruitment PLoS ONE 8 2013 e55325
38. M. Elvers Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1 Sci. Signal. 3 2010 ra1
39. I. Thielmann Redundant functions of phospholipases D1 and D2 in platelet alpha-granule release J. Thromb. Haemost. 10 2012 2361 2372
40. A.T. Cohen The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders Thromb. Res. 2014 10.1016/j.thromres.2014.11.036 Published online December 13, 2014
41. L.M. Wuescher A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against S. aureus bacteremia J. Thromb. Haemost. 2014 10.1111/jth.12795 Published online November 22, 2014
42. T. Schonberger Pivotal role of phospholipase D1 in tumor necrosis factor-alpha-mediated inflammation and scar formation after myocardial ischemia and reperfusion in mice Am. J. Pathol. 184 2014 2450 2464
43. R. Jaafar Phospholipase D regulates the size of skeletal muscle cells through the activation of mTOR signaling Cell Commun. Signal. 11 2013 55
44. M.S. Yoon, and J. Chen Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis Mol. Biol. Cell 24 2013 3754 3763
45. S. Teng Phospholipase D1 facilitates second phase myoblast fusion and skeletal muscle regeneration Mol. Biol. Cell 2014 Published online November 26, 2014. http://dx.doi.org/mbc.E14-03-0802
46. A. Karlas Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication Nature 463 2010 818 822
47. T.H. Oguin, and 3rd Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition J. Biol. Chem. 289 2014 25405 25417
48. D. Cai Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation Proc. Natl. Acad. Sci. U.S.A. 103 2006 1941 1946
49. T.G. Oliveira Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits J. Neurosci. 30 2010 16419 16428
50. B. Jiao Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China Neurobiol. Aging 35 2014 2422.e9-2422.e11
51. U. Burkhardt Impaired brain development and reduced cognitive function in phospholipase D-deficient mice Neurosci. Lett. 572 2014 48 52
52. K. Gobel Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis Eur. J. Immunol. 44 2014 2295 2305
53. K.W. Hong Non-synonymous single-nucleotide polymorphisms associated with blood pressure and hypertension J. Hum. Hypertens. 24 2010 763 774
54. G. Du Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis Mol. Biol. Cell 15 2004 1024 1030
55. H. Qin Phospholipase D2 mediates acute aldosterone secretion in response to angiotensin II in adrenal glomerulosa cells Endocrinology 151 2010 2162 2170
56. Y.Y. Tsai Phospholipase D activity underlies very-low-density lipoprotein (VLDL)-induced aldosterone production in adrenal glomerulosa cells Endocrinology 155 2014 3550 3560
57. M. Labelle, and R.O. Hynes The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination Cancer Discov. 2 2012 1091 1099
58. J. Ghim Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis Arterioscler. Thromb. Vasc. Biol. 34 2014 1697 1703
59. S. Han Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid Exp. Mol. Med. 46 2014 e126
60. R.C. Bruntz Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells J. Biol. Chem. 289 2014 600 616
61. K.M. Henkels Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model Oncogene 32 2013 5551 5562
62. F. Zhang Temporal production of the signaling lipid phosphatidic acid by phospholipase D2 determines the output of extracellular signal-regulated kinase signaling in cancer cells Mol. Cell. Biol. 34 2014 84 95
63. A. Mor Phospholipase D1 regulates lymphocyte adhesion via upregulation of Rap1 at the plasma membrane Mol. Cell. Biol. 29 2009 3297 3306
64. A. Montresor Comparative analysis of normal versus CLL B-lymphocytes reveals patient-specific variability in signaling mechanisms controlling LFA-1 activation by chemokines Cancer Res. 69 2009 9281 9290
65. G.M. Jenkins, and M.A. Frohman Phospholipase D: a lipid centric review Cell. Mol. Life Sci. 62 2005 2305 2316